StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > New VP Business Development - Europe

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Oct 04, 2024 7:38pm

54 Views

Post# 36254103

RE:RE:New VP Business Development - Europe

Well, here you are again nailbiter2 with a stranglehold on the obvious after LL does the heavy lifting.
Pumping/attaching yourself to ride on someone else's work.

You went to a website LL provided and did a copy and paste. You are shameless.

Gooood boy.

Nailbiter2 wrote: Good catch LL.
Awesome DD.
Now we sit for upcoming news.
Pieces slowly coming together... Finallllllly

LithLover wrote: New position just hired in August 2024 (while under a trade halt).

The person comes with 5 years from Aidian and 5 years Orion Diagnostica Oy.

2 large diagnostic testing companies in Finland and Germany.

Now working with Stagezero/COC.